Reviews in Endocrine & Metabolic Disorders

Papers
(The H4-Index of Reviews in Endocrine & Metabolic Disorders is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Association between continuous glucose monitoring metrics and cardiovascular autonomic neuropathy in diabetic patients: a systematic review172
Pathophysiological insights into asprosin: an emerging adipokine in reproductive health119
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality119
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review98
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb96
Traumatic brain injury and prolactin84
Looking beyond fat in obesity: the frequently overlooked importance of muscle mass84
Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review75
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus63
The genetics of Graves’ disease63
Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus60
Endocrine responses of the stress system to different types of exercise54
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review53
Diagnostic and prognostic utility of phase angle in patients with cancer53
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?53
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond48
Androgens, aging, and prostate health47
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease44
Posttranslational modifications in diabetes: Mechanisms and functions44
Preface43
Prolactin deficiency in the context of other pituitary hormone abnormalities43
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence42
Emerging role of AgRP neurons as integrators of metabolic, sensory and environmental cues in the control of energy homeostasis42
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease42
Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic42
Mention to Prof. Andrew V. Schally40
No longer to be ignored: Hypophosphatemia following intravenous iron administration39
Hypothalamic GHRH39
Neurovascular plasticity as a modulator of hypothalamic function37
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review37
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy36
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis35
Appetitive interoception, the hippocampus and western-style diet35
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries35
Deep neural network for food image classification and nutrient identification: A systematic review35
0.032460927963257